IL15 and neoplasm: As a pleiotropic cytokine with an immune-potentiating effect on both T cells and natural killer (NK) cells, IL-15 armoring has also been reported to improve the antitumor activity of human CAR-T cells targeting multiple antigens across both blood and solid xenograft tumor models (14–18).